scholarly article | Q13442814 |
P356 | DOI | 10.1016/0003-4975(95)00374-T |
P698 | PubMed publication ID | 7598572 |
P2093 | author name string | Chiu RC | |
Zibaitis A | |||
Kao RL | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 12-18 | |
P577 | publication date | 1995-07-01 | |
P1433 | published in | The Annals of Thoracic Surgery | Q1939819 |
P1476 | title | Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation | |
P478 | volume | 60 |
Q91653580 | A Visible Light-Cross-Linkable, Fibrin-Gelatin-Based Bioprinted Construct with Human Cardiomyocytes and Fibroblasts |
Q37205243 | A comparative study of magnetic-activated cell sorting, cytotoxicity and preplating for the purification of human myoblasts |
Q58756008 | A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes |
Q35842254 | Adult-derived stem cells from the liver become myocytes in the heart in vivo |
Q42821299 | Advances in cell transplantation therapy for diseased myocardium. |
Q37293786 | Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells |
Q44934257 | Aneural culture of rat myoblasts for myocardial transplant |
Q73315627 | Autologous heart cell transplantation improves cardiac function after myocardial injury |
Q37800141 | Cardiac cell therapies: the next generation |
Q36579504 | Cardiac repair--fact or fancy? |
Q27301781 | Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium |
Q36559155 | Cell therapy: a 21st-century hope for treating cardiovascular disease--what do the next 5 years hold? |
Q37187645 | Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction |
Q44687812 | Cell transplantation to prevent heart failure: a comparison of cell types. |
Q58555709 | Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies |
Q36667275 | Cell-based approaches for cardiac repair |
Q33774545 | Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling |
Q37638266 | Cellular cardiomyoplasty and cardiac regeneration |
Q24806964 | Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure |
Q34766680 | Cellular cardiomyoplasty--a novel approach to treat heart disease |
Q50793385 | Comparing the transcriptional profile of mesenchymal cells to cardiac and skeletal muscle cells. |
Q45644333 | Cord blood cell therapy alters LV remodeling and cytokine expression but does not improve heart function after myocardial infarction in rats |
Q38058287 | Current status of myocardial regeneration therapy |
Q35184029 | Diabetic heart dysfunction: is cell transplantation a potential therapy? |
Q36327602 | Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair |
Q36804481 | Engineering the heart piece by piece: state of the art in cardiac tissue engineering |
Q37302427 | Fabrication of skeletal muscle constructs by topographic activation of cell alignment. |
Q73090517 | First human myoblast transfer therapy continues to show dystrophin after 6 years |
Q41789265 | Gene transfer into canine myoblasts |
Q34387398 | Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts |
Q37766154 | Getting to the heart of tissue engineering. |
Q41252489 | Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix |
Q41122153 | Hybrid muscular tissues: preparation of skeletal muscle cell-incorporated collagen gels |
Q34704423 | Is in vivo remodeling necessary or sufficient for cellular repair of the heart? |
Q74341231 | Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects |
Q37296154 | Metabolic modulation and cellular therapy of cardiac dysfunction and failure |
Q35146911 | Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host |
Q37014360 | Myocardial tissue engineering: a review. |
Q40785082 | Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium |
Q59016381 | Nanoscaffolds for Guided Cardiac Repair: The New Therapeutic Challenge of Regenerative Medicine |
Q38074105 | Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells. |
Q35949674 | Neovascularization derived from cell transplantation in ischemic myocardium. |
Q38982831 | Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology |
Q37769841 | Oxygen and oxygenation in stem-cell therapy for myocardial infarction |
Q34039522 | Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies |
Q27687840 | Regenerating functional heart tissue for myocardial repair |
Q35184059 | Reprogramming cells for transplantation. |
Q37766134 | Review of stem cell-based therapy for the treatment of cardiovascular disease |
Q37596307 | Saving hearts through basic research |
Q37361791 | Skeletal myoblast transplantation for repair of myocardial necrosis |
Q53537606 | Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. |
Q28069300 | Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? |
Q36586569 | Stem cell transplantation: potential impact on heart failure |
Q36842866 | Stem cells and cardiac regeneration |
Q37766151 | Stem cells and cardiac repair: a critical analysis |
Q35192887 | Stem cells and cardiovascular disease |
Q35832759 | Stem cells and repair of the heart. |
Q79175167 | Stem cells to regenerate cardiac tissue in heart failure |
Q36203033 | Surgical ventricular restoration and other surgical approaches to heart failure |
Q35475301 | Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs |
Q36984663 | Systems approaches to preventing transplanted cell death in cardiac repair. |
Q58267737 | Technical delivery of myogenic cells through an endocardial injection catheter for myocardial cell implantation |
Q37560012 | The Role of Immunogenicity in Cardiovascular Disease |
Q36174197 | The bone marrow--cardiac axis of myocardial regeneration |
Q40833666 | Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? |
Q33683767 | Unchain my heart: the scientific foundations of cardiac repair |
Search more.